NGM·Healthcare·$78M·#52 / 520 in Healthcare
BTMD Biote Corp.
71SOLID
CATEGORY BREAKDOWN
GROWTH0
QUALITY78
STABILITY100
VALUATION100
GOVERNANCE76
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-2.5%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
71.5%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-187.8%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.4x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
16
44
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
9.8%
64
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-3.1%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BTMD WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BTMD's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.